$TMHC
Taylor Morrison Home Corp

2023 Q2 Form 10-Q Financial Statement

#000095017023014795 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $2.061B $1.662B
YoY Change 3.29% -2.42%
Cost Of Revenue $1.561B $1.262B
YoY Change 7.38% -3.64%
Gross Profit $499.7M $399.6M
YoY Change -7.72% 1.64%
Gross Profit Margin 24.25% 24.04%
Selling, General & Admin $183.7M $159.0M
YoY Change 10.96% 1.12%
% of Gross Profit 36.76% 39.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.391M $7.087M
YoY Change -17.11% -19.84%
% of Gross Profit 1.48% 1.77%
Operating Expenses $192.2M $159.0M
YoY Change 16.12% 1.12%
Operating Profit $307.5M $240.5M
YoY Change -18.22% 1.99%
Interest Expense $8.306M $3.040M
YoY Change -194.11% -225.57%
% of Operating Profit 2.7% 1.26%
Other Income/Expense, Net -$3.429M $5.945M
YoY Change -158.87% -224.01%
Pretax Income $315.8M $248.4M
YoY Change -19.37% 6.66%
Income Tax $80.85M $57.19M
% Of Pretax Income 25.61% 23.02%
Net Earnings $234.6M $191.1M
YoY Change -19.38% 8.12%
Net Earnings / Revenue 11.39% 11.5%
Basic Earnings Per Share $2.15 $1.76
Diluted Earnings Per Share $2.12 $1.74
COMMON SHARES
Basic Shares Outstanding 109.1M 108.3M shares
Diluted Shares Outstanding 110.9M 110.1M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.227B $877.7M
YoY Change 224.38% 54.19%
Cash & Equivalents $1.227B $877.7M
Short-Term Investments
Other Short-Term Assets $261.1M $225.4M
YoY Change 66.02% -16.89%
Inventory $5.234B $5.333B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $6.912B $6.632B
YoY Change 2.34% -1.59%
LONG-TERM ASSETS
Property, Plant & Equipment $304.4M $213.4M
YoY Change 38.23% 2.62%
Goodwill $663.2M $663.2M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $514.2M $522.9M
YoY Change -9.77% 20.45%
Other Assets $355.4M $260.6M
YoY Change 0.0% -31.87%
Total Long-Term Assets $1.837B $1.744B
YoY Change -3.13% -1.95%
TOTAL ASSETS
Total Short-Term Assets $6.912B $6.632B
Total Long-Term Assets $1.837B $1.744B
Total Assets $8.749B $8.376B
YoY Change 1.14% -1.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $281.6M $247.9M
YoY Change -3.35% 10.02%
Accrued Expenses $500.4M $464.9M
YoY Change 4.83% -0.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.166B $1.130B
YoY Change -13.68% -9.38%
LONG-TERM LIABILITIES
Long-Term Debt $2.394B $2.302B
YoY Change -18.88% -24.49%
Other Long-Term Liabilities $94.16M $97.89M
YoY Change -39.28% -23.51%
Total Long-Term Liabilities $2.488B $2.400B
YoY Change -19.9% -24.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.166B $1.130B
Total Long-Term Liabilities $2.488B $2.400B
Total Liabilities $3.670B $3.530B
YoY Change -17.63% -20.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.078B $4.830B
YoY Change
Total Liabilities & Shareholders Equity $8.749B $8.376B
YoY Change 1.14% -1.66%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $234.6M $191.1M
YoY Change -19.38% 8.12%
Depreciation, Depletion And Amortization $7.391M $7.087M
YoY Change -17.11% -19.84%
Cash From Operating Activities $259.7M $347.4M
YoY Change 88.12% 504.67%
INVESTING ACTIVITIES
Capital Expenditures $7.238M $13.81M
YoY Change -197.65% 156.21%
Acquisitions
YoY Change
Other Investing Activities -$13.01M -$10.77M
YoY Change -168.31% 425.0%
Cash From Investing Activities -$20.25M -$24.58M
YoY Change -274.05% 230.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 104.2M -165.1M
YoY Change -130.53% -47.69%
NET CHANGE
Cash From Operating Activities 259.7M 347.4M
Cash From Investing Activities -20.25M -24.58M
Cash From Financing Activities 104.2M -165.1M
Net Change In Cash 343.6M 157.8M
YoY Change -279.39% -159.43%
FREE CASH FLOW
Cash From Operating Activities $259.7M $347.4M
Capital Expenditures $7.238M $13.81M
Free Cash Flow $252.4M $333.6M
YoY Change 73.56% 540.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109112512
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
877717000
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001562476
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35873
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
TAYLOR MORRISON HOME CORP
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2026677
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4900 N. Scottsdale Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2000
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023Q1 dei City Area Code
CityAreaCode
480
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
840-8100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
TMHC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
724488000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6717000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2147000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
884434000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726635000
CY2023Q1 tmhc Inventory Real Estate Owned
InventoryRealEstateOwned
5330548000
CY2022Q4 tmhc Inventory Real Estate Owned
InventoryRealEstateOwned
5346905000
CY2023Q1 tmhc Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
2295000
CY2022Q4 tmhc Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
23971000
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
5332843000
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
5370876000
CY2023Q1 us-gaap Deposits Assets
DepositsAssets
228117000
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
263356000
CY2023Q1 us-gaap Trade And Loans Receivables Held For Sale Net Not Part Of Disposal Group
TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup
186194000
CY2022Q4 us-gaap Trade And Loans Receivables Held For Sale Net Not Part Of Disposal Group
TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup
346364000
CY2023Q1 tmhc Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
84052000
CY2022Q4 tmhc Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
90446000
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
225381000
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
265392000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
196184000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
191504000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
294755000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
282900000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
67656000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
67656000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
213374000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202398000
CY2023Q1 us-gaap Goodwill
Goodwill
663197000
CY2022Q4 us-gaap Goodwill
Goodwill
663197000
CY2023Q1 us-gaap Assets
Assets
8376187000
CY2022Q4 us-gaap Assets
Assets
8470724000
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
247887000
CY2022Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
269761000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
424619000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
490253000
CY2023Q1 tmhc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
92895000
CY2022Q4 tmhc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
100174000
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2977000
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
414085000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
412092000
CY2023Q1 tmhc Estimated Development Liability
EstimatedDevelopmentLiability
43005000
CY2022Q4 tmhc Estimated Development Liability
EstimatedDevelopmentLiability
43753000
CY2023Q1 us-gaap Senior Notes
SeniorNotes
1816877000
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1816303000
CY2023Q1 us-gaap Loans Payable
LoansPayable
338667000
CY2022Q4 us-gaap Loans Payable
LoansPayable
361486000
CY2023Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
146334000
CY2022Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
306072000
CY2023Q1 tmhc Liabilities Attributable To Consolidated Option Agreements
LiabilitiesAttributableToConsolidatedOptionAgreements
2295000
CY2022Q4 tmhc Liabilities Attributable To Consolidated Option Agreements
LiabilitiesAttributableToConsolidatedOptionAgreements
23971000
CY2023Q1 us-gaap Liabilities
Liabilities
3529641000
CY2022Q4 us-gaap Liabilities
Liabilities
3823865000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4846546000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646859000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8376187000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8470724000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1661857000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1703124000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1262291000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1309996000
CY2023Q1 us-gaap Gross Profit
GrossProfit
399566000
CY2022Q1 us-gaap Gross Profit
GrossProfit
393128000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
92760000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
89123000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66261000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68142000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1929000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1831000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1111000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4252000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4834000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-542000
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
248419000
CY2022Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
232900000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57191000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54439000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
191228000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
178461000
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable
177000
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Joint Venture Partners Redeemable
NoncontrollingInterestInNetIncomeLossJointVenturePartnersRedeemable
1758000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
191051000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
176703000
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.76
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.46
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.74
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.44
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108429000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121186000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110053000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122657000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646859000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
191228000
CY2023Q1 tmhc Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net
StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet
4493000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3568000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
7533000
CY2023Q1 tmhc Noncontrolling Interest Increase Decrease From Contributions Distributions To Noncontrolling Interest Holders
NoncontrollingInterestIncreaseDecreaseFromContributionsDistributionsToNoncontrollingInterestHolders
1000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4846546000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13500000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3970982000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
178461000
CY2022Q1 tmhc Stock Issued Value Exercise Of Stock Options And Issuance Of Restricted Stock Units Net
StockIssuedValueExerciseOfStockOptionsAndIssuanceOfRestrictedStockUnitsNet
-1265000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
58029000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
6863000
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1752000
CY2022Q1 tmhc Noncontrolling Interest Increase Decrease From Contributions Distributions To Noncontrolling Interest Holders
NoncontrollingInterestIncreaseDecreaseFromContributionsDistributionsToNoncontrollingInterestHolders
-462000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4094798000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2400000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
191228000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
178461000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1929000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1831000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7533000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6863000
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
847000
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2058000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7087000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8841000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
7144000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
6913000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
868000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
191000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-51596000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
286828000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-190202000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-171618000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1993000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
55211000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-112097000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
138247000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2977000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
54211000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
347449000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57461000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13807000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5389000
CY2023Q1 tmhc Distributions Of Capital From Unconsolidated Entities
DistributionsOfCapitalFromUnconsolidatedEntities
350000
CY2022Q1 tmhc Distributions Of Capital From Unconsolidated Entities
DistributionsOfCapitalFromUnconsolidatedEntities
0
CY2023Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
11123000
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2052000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24580000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7441000
CY2023Q1 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
2425000
CY2022Q1 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
18287000
CY2023Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
7377000
CY2022Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
26688000
CY2023Q1 tmhc Proceeds From Revolving Credit Facility
ProceedsFromRevolvingCreditFacility
0
CY2022Q1 tmhc Proceeds From Revolving Credit Facility
ProceedsFromRevolvingCreditFacility
32548000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
64077000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
634404000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
562024000
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
794142000
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
775249000
CY2023Q1 tmhc Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net
ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet
4493000
CY2022Q1 tmhc Proceeds From Stock Option Exercises And Issuance Of Restricted Stock Units Net
ProceedsFromStockOptionExercisesAndIssuanceOfRestrictedStockUnitsNet
-1265000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1305000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1332000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3568000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
58029000
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1752000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-165070000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-315533000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
157799000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-265513000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726635000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
836340000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
884434000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
570827000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1943000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
228000
CY2023Q1 tmhc Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts
IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts
-39865000
CY2022Q1 tmhc Increase Decrease In Loans Payable Issued To Sellers In Connection With Land Purchase Contracts
IncreaseDecreaseInLoansPayableIssuedToSellersInConnectionWithLandPurchaseContracts
-59830000
CY2023Q1 tmhc Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned
NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned
-21676000
CY2022Q1 tmhc Noncash Investing And Financing Activities Increase Decrease In Inventory Not Owned
NoncashInvestingAndFinancingActivitiesIncreaseDecreaseInInventoryNotOwned
-11896000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108429000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121186000
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
913000
CY2022Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
801000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
711000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
670000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> — The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the amounts reported in the unaudited Condensed Consolidated Financial Statements and these accompanying notes. Significant estimates include real estate development costs to complete, valuation of real estate, valuation of acquired assets, valuation of goodwill, valuation of development liabilities, valuation of equity awards, valuation allowance on deferred tax assets, and reserves for warranty and self-insured risks. Actual results could differ from those estimates.</span></p>
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
191051000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
176703000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110053000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122657000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.76
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.44
CY2023Q1 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
3618428000
CY2022Q4 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
3607227000
CY2023Q1 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
48881000
CY2022Q4 us-gaap Real Estate Held For Development And Sale
RealEstateHeldForDevelopmentAndSale
43314000
CY2023Q1 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
1466632000
CY2022Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
1506241000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
196607000
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
190123000
CY2023Q1 tmhc Inventory Real Estate Owned
InventoryRealEstateOwned
5330548000
CY2022Q4 tmhc Inventory Real Estate Owned
InventoryRealEstateOwned
5346905000
CY2023Q1 tmhc Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
2295000
CY2022Q4 tmhc Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
23971000
CY2023Q1 us-gaap Inventory Real Estate
InventoryRealEstate
5332843000
CY2022Q4 us-gaap Inventory Real Estate
InventoryRealEstate
5370876000
CY2023Q1 tmhc Number Of Lots Under Option
NumberOfLotsUnderOption
30657
CY2023Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
2523892000
CY2023Q1 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
222165000
CY2022Q4 tmhc Number Of Lots Under Option
NumberOfLotsUnderOption
30842
CY2022Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
2442389000
CY2022Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
254549000
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
190123000
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
168670000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
34133000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
39729000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
27649000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
30430000
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
196607000
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
177969000
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2312071000
CY2023Q1 tmhc Real Estate Land And Land Development Costs
RealEstateLandAndLandDevelopmentCosts
52589000
CY2022Q4 tmhc Real Estate Land And Land Development Costs
RealEstateLandAndLandDevelopmentCosts
53155000
CY2023Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
68029000
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
112294000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
158222000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
161675000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
26558000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
37434000
CY2023Q1 tmhc Accrued Property And Sales Tax
AccruedPropertyAndSalesTax
24069000
CY2022Q4 tmhc Accrued Property And Sales Tax
AccruedPropertyAndSalesTax
30046000
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
95152000
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
95649000
CY2023Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
424619000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
490253000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
161675000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
141839000
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
14447000
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8884000
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
20508000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
12473000
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2608000
CY2022Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
2720000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
158222000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
140970000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10193000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
2301878000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2494628000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-10767000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
2483861000
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
146334000
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
350000000
CY2022Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
306072000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
495000000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
279138000
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
230413000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3568000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
58029000
CY2023Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
275570000
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
172384000
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
109325
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1948187
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7533000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6863000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
43100000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
27100000
CY2023Q1 tmhc Number Of Reportable Segments Included In Operating Component
NumberOfReportableSegmentsIncludedInOperatingComponent
3
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1661857000
CY2023Q1 us-gaap Gross Profit
GrossProfit
399566000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
159021000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1929000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5945000
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
248419000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1703124000
CY2022Q1 us-gaap Gross Profit
GrossProfit
393128000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
157265000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1831000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4794000
CY2022Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
232900000
CY2023Q1 tmhc Real Estate Inventory And Land Deposits
RealEstateInventoryAndLandDeposits
5560960000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
294755000
CY2023Q1 us-gaap Other Assets
OtherAssets
2520472000
CY2023Q1 us-gaap Assets
Assets
8376187000
CY2022Q4 tmhc Real Estate Inventory And Land Deposits
RealEstateInventoryAndLandDeposits
5634232000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
282900000
CY2022Q4 us-gaap Other Assets
OtherAssets
2553592000
CY2022Q4 us-gaap Assets
Assets
8470724000
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1300000000
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1200000000
CY2023Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
17500000
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
20600000
CY2023Q1 tmhc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
92900000
CY2022Q4 tmhc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
100200000
CY2023Q1 us-gaap Lease Cost
LeaseCost
7100000
CY2022Q1 us-gaap Lease Cost
LeaseCost
6900000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
1381000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
3476000
CY2023Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
496500000
CY2022Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
419600000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-014795-index-headers.html Edgar Link pending
0000950170-23-014795-index.html Edgar Link pending
0000950170-23-014795.txt Edgar Link pending
0000950170-23-014795-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmhc-20230331.htm Edgar Link pending
tmhc-20230331.xsd Edgar Link pending
tmhc-ex31_1.htm Edgar Link pending
tmhc-ex31_2.htm Edgar Link pending
tmhc-ex32_1.htm Edgar Link pending
tmhc-ex32_2.htm Edgar Link pending
tmhc-20230331_cal.xml Edgar Link unprocessable
tmhc-20230331_def.xml Edgar Link unprocessable
tmhc-20230331_lab.xml Edgar Link unprocessable
tmhc-20230331_pre.xml Edgar Link unprocessable
tmhc-20230331_htm.xml Edgar Link completed